BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yuan Y, Cai X, Shen F, Ma F. HPV post-infection microenvironment and cervical cancer. Cancer Lett 2021;497:243-54. [PMID: 33122098 DOI: 10.1016/j.canlet.2020.10.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Han Y, Bai C, He XM, Ren QL. P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells. Purinergic Signal 2022. [PMID: 35235139 DOI: 10.1007/s11302-022-09854-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Franciosi MLM, do Carmo TIT, Zanini D, Cardoso AM. Inflammatory profile in cervical cancer: influence of purinergic signaling and possible therapeutic targets. Inflamm Res 2022. [PMID: 35376994 DOI: 10.1007/s00011-022-01560-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qi L, Zhou H, Wang Y, Jablonska E, Wang M, Su S, Jia Y, Wang R, Jiang M, Wang Y, Zhang Y, Li Q, Wang T. The role of selenoprotein P in the determining the sensitivity of cervical cancer patients to concurrent chemoradiotherapy: A metabonomics-based analysis. J Trace Elem Med Biol 2022;73:127041. [PMID: 35905604 DOI: 10.1016/j.jtemb.2022.127041] [Reference Citation Analysis]
4 Wei W, Xie LZ, Xia Q, Fu Y, Liu FY, Ding DN, Han FJ. The role of vaginal microecology in the cervical cancer. J Obstet Gynaecol Res 2022. [PMID: 35815344 DOI: 10.1111/jog.15359] [Reference Citation Analysis]
5 Jin J, Du X, Zhou L, Yao D, Zou Q. SPI1-related protein inhibits cervical cancer cell progression and prevents macrophage cell migration. J Obstet Gynaecol Res 2022. [PMID: 35770729 DOI: 10.1111/jog.15336] [Reference Citation Analysis]
6 Xu F, Shen J, Xu S. Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment. Front Cell Dev Biol 2021;9:637400. [PMID: 33553190 DOI: 10.3389/fcell.2021.637400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hu C, Liu T, Han C, Xuan Y, Jiang D, Sun Y, Zhang X, Zhang W, Xu Y, Liu Y, Pan J, Wang J, Fan J, Che Y, Huang Y, Zhang J, Ding J, Yang S, Yang K. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression. Int J Biol Sci 2022;18:507-21. [PMID: 35002506 DOI: 10.7150/ijbs.67770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Purzycka-Bohdan D, Nowicki RJ, Herms F, Casanova JL, Fouéré S, Béziat V. The Pathogenesis of Giant Condyloma Acuminatum (Buschke-Lowenstein Tumor): An Overview. Int J Mol Sci 2022;23:4547. [PMID: 35562936 DOI: 10.3390/ijms23094547] [Reference Citation Analysis]
9 Yang S, Zhao Q, Tang L, Chen Z, Wu Z, Li K, Lin R, Chen Y, Ou D, Zhou L, Xu J, Qin Q. Whole Genome Assembly of Human Papillomavirus by Nanopore Long-Read Sequencing. Front Genet 2021;12:798608. [PMID: 35058971 DOI: 10.3389/fgene.2021.798608] [Reference Citation Analysis]
10 Fleischmann M, Chatzikonstantinou G, Fokas E, Wichmann J, Christiansen H, Strebhardt K, Rödel C, Tselis N, Rödel F. Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers (Basel) 2021;13:5748. [PMID: 34830902 DOI: 10.3390/cancers13225748] [Reference Citation Analysis]
11 Chiantore MV, Iuliano M, Mongiovì RM, Dutta S, Tommasino M, Di Bonito P, Accardi L, Mangino G, Romeo G. The E6 and E7 proteins of beta3 human papillomavirus 49 can deregulate both cellular and extracellular vesicles-carried microRNAs. Infect Agent Cancer 2022;17:29. [PMID: 35705991 DOI: 10.1186/s13027-022-00445-z] [Reference Citation Analysis]
12 Bañuelos-Villegas EG, Pérez-yPérez MF, Alvarez-Salas LM. Cervical Cancer, Papillomavirus, and miRNA Dysfunction. Front Mol Biosci 2021;8:758337. [PMID: 34957212 DOI: 10.3389/fmolb.2021.758337] [Reference Citation Analysis]
13 Gu YY, Zhou GN, Li Y, He HY, Ding JX, Hua KQ, Cao S. HDAC10 Inhibits Cervical Cancer Progression through Downregulating the HDAC10-microRNA-223-EPB41L3 Axis. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/8092751] [Reference Citation Analysis]
14 Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers (Basel) 2021;13:6062. [PMID: 34885171 DOI: 10.3390/cancers13236062] [Reference Citation Analysis]
15 Zhang W, Xiao P, Tang J, Wang R, Wang X, Wang F, Ruan J, Yu S, Tang J, Huang R, Zhao X. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. Front Immunol 2022;13:888650. [DOI: 10.3389/fimmu.2022.888650] [Reference Citation Analysis]
16 Hu Q, Wang Y, Zhang Y, Ge Y, Yin Y, Zhu H. A New HPV score System Predicts the Survival of Patients With Cervical Cancers. Front Genet 2021;12:747090. [PMID: 34925445 DOI: 10.3389/fgene.2021.747090] [Reference Citation Analysis]
17 Di Fiore R, Suleiman S, Drago-Ferrante R, Subbannayya Y, Pentimalli F, Giordano A, Calleja-Agius J. Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review. Int J Mol Sci 2022;23:5167. [PMID: 35563557 DOI: 10.3390/ijms23095167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhu L, Zhao Y, Yao S, Xu M, Yin L, Zhai X, Teng X. A colorimetric aptasensor for the simple and rapid detection of human papillomavirus type 16 L1 proteins. Analyst 2021;146:2712-7. [PMID: 33688885 DOI: 10.1039/d1an00251a] [Reference Citation Analysis]
19 Zheng X, Zhu Y, Wang X, Hou Y, Fang Y. Silencing of ITGB6 inhibits the progression of cervical carcinoma via regulating JAK/STAT3 signaling pathway. Ann Transl Med 2021;9:803. [PMID: 34268416 DOI: 10.21037/atm-21-1669] [Reference Citation Analysis]
20 Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res 2020;32:720-8. [PMID: 33446995 DOI: 10.21147/j.issn.1000-9604.2020.06.05] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
21 Xiao L, Zhang S, Zheng Q, Zhang S. Dysregulation of KIF14 regulates the cell cycle and predicts poor prognosis in cervical cancer: a study based on integrated approaches. Braz J Med Biol Res 2021;54:e11363. [PMID: 34495250 DOI: 10.1590/1414-431X2021e11363] [Reference Citation Analysis]
22 Shi Y, Liu M, Wu H, Han Y, He X, Shi Z. GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer. Disease Markers 2022;2022:1-14. [DOI: 10.1155/2022/9109365] [Reference Citation Analysis]